In co-culture, FCRL5 CAR-T cells displayed enhanced tumor-killing ability at lower effector:target (E:T) ratios (Fig. 2d), superior recognition of NCI-H929 and FCRL5+MM1.S cells (Fig. 2e) and resulted in enhanced cell death than BCMA CAR-T cells (Fig. 2f). The gene discussed is FCRL5; the disease is neoplasm.